Exhibit 99.1
Joint Filing Agreement
The undersigned hereby agree that the Statement on Schedule 13G dated January 2, 2018 with respect to the shares of Common Stock of Akers Biosciences, Inc., and any further amendments thereto executed by each and any of the undersigned shall be filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended.
Dated: January 2, 2018
| Bigger Capital Fund, LP | Bigger Capital Fund GP, LLC | |||
| /s/ Michael Bigger | ||||
| By: | Bigger Capital Fund GP, LLC, its general partner | By: | Michael Bigger | |
| Managing Member | ||||
| By: |
/s/ Michael Bigger |
|||
| Michael Bigger | ||||
| Managing Member | /s/ Michael Bigger | |||
| Michael Bigger | ||||